Spark Therapeutics Analysis
Spark Therapeutics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Spark Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Spark Therapeutics is worth, separate from its market price. There are two main types of Spark Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Spark Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Spark Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Spark Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Spark Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Spark Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Spark Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Spark |
Spark Stock Analysis Notes
About 92.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 6.1. Spark Therapeutics had not issued any dividends in recent years. Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Spark Therapeutics, Inc. was founded in 2013 and is headquartered in Philadelphia, Pennsylvania. Spark Therapeutics operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 368 people. To find out more about Spark Therapeutics contact Jeffrey Marrazzo at 888 772-7560 or learn more at www.sparktx.com.Spark Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Spark Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Spark Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Spark Therapeutics is not yet fully synchronised with the market data | |
| Spark Therapeutics has some characteristics of a very speculative penny stock | |
| Spark Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 58.14 M. Net Loss for the year was (231.2 M) with profit before overhead, payroll, taxes, and interest of 56.81 M. | |
| Spark Therapeutics currently holds about 400.84 M in cash with (156.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.41. | |
| Over 92.0% of the company shares are owned by institutional investors |
Spark Therapeutics Thematic Classifications
In addition to having Spark Therapeutics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Aggressive DefenceSmall capitalization, high growth potential companies |
Spark Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.38 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Spark Therapeutics's market, we take the total number of its shares issued and multiply it by Spark Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Spark Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Spark Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Spark Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Spark Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Stephen Webster over a year ago Payment of 635 shares by Stephen Webster of Spark Therapeutics subject to Rule 16b-3 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Spark Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Spark Therapeutics information on this page should be used as a complementary analysis to other Spark Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Spark Stock
If you are still planning to invest in Spark Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spark Therapeutics' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |